Drawing for CARI-PLAQUE

USPTO serial 79414254

CARI-PLAQUE

Reviewed by CopyMark Law Group

Reg. 8330001Status 700Registered
Filing date
Status date
Registration date
Jul 7, 2026
Examiner
RUMMERY, MARY M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CARI-PLAQUE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory J. Chinlund

Gregory J. Chinlund Marshall, Gerstein & Borun LLP233 South Wacker Drive, Suite 6300Chicago, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for receiving, processing, transmitting, analysing, organising and displaying data, all for use with medical patient monitoring, diagnostic and prognostic equipment; downloadable computer software for controlling and managing patient medical information; downloadable computer software for medical equipment, namely, software for interpreting results from diagnostic and prognostic equipment; downloadable computer software for operating medical diagnostic and prognostic equipment; none of the aforementioned goods for use in the fields of workplace wellbeing, mental health, occupational psychology, coaching, training, performance monitoring and management, organisational metrics in engagement and culture.ACTIVE—
035Compilation of information into computer databases in the field of medical reportsACTIVE—
042Software development, programming and implementation in the field of medical imaging; medical and pharmacological research services; medical research; medical research services; scientific investigations for medical purposes; scientific research for medical purposes; Software as a service (SAAS) services featuring computer software platforms using artificial intelligence for detection, diagnosis, prognosis and treatment of disease including cardiovascular, neurological and metabolic disease; software design and development; software engineering; Providing computer aided diagnostic vascular testing services for others for scientific research purposes; computer programming in the medical field; Software as a service (SaaS) services featuring software for machine learning, collection, analysis and organisation of data in the field of deep learning and operation of deep neural networks; Software as a service (SAAS) services featuring software for the visualisation, analysis, and reporting of information relating to vascular anatomy and plaque content from patient medical imaging data; software as a service (SaaS) for interpreting and analysing results from diagnostic and prognostic equipment; Software as a service (SaaS) services for processing images relating to CT image analysis; Software as a service (SaaS) services featuring software for the analysis of data enabling the early detection, diagnosis, prognosis and treatment of disease including cardiovascular and metabolic disease; information, advisory and consultancy services relating to the aforesaid; none of the aforementioned services provided in respect of workplace wellbeing, mental health, occupational psychology, coaching, training, performance monitoring and management, organisational metrics in engagement and culture.ACTIVE—
044Medical diagnostic and prognostic services; Issuing of medical diagnostic reports; medical analysis for the diagnosis, prognosis and treatment of persons; medical analysis services relating to the treatment of persons; medical testing for diagnostic, prognostic or treatment purposes; consulting services relating to health care; human healthcare services; medical imaging services; information, advisory and consultancy services relating to the aforesaid; none of the aforementioned services provided in respect of workplace wellbeing, mental health, occupational psychology, coaching, training, performance monitoring and management, organisational metrics in engagement and culture.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 7, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 7, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 25, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 8, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 8, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 19, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 19, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 21, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 20, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 20, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 20, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 21, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 21, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 21, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 11, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 11, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 11, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 29, 2025RFNTREFUSAL PROCESSED BY IB—
Mar 11, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 11, 2025RFRRREFUSAL PROCESSED BY MPU—
Jan 23, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 22, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 11, 2025DOCKASSIGNED TO EXAMINER—
Jan 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 9, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance